- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Shares of Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) gain almost half their value on word that its interim results Phase II trials showed that the combined use of its bavituximab drug candidate with chemotherapy drug docetaxel caused a statistically significant improvement in the overall survival rate for lung cancer patients.
Opexa Therapeutics, Inc. (NASDAQ:OPXA) moves up on the signing of a sales agreement with Brinson Patrick Securities, through which the firm can sell shares of its common stock, with Brinson Patrick Securities as its sales agent on a 3 percent commission.
The board of Neptune Technologies & Bioresources Inc. (NASDAQ:NEPT) okays dividend-in-kind distribution and a record date for a partial spin-off of its NeuroBioPharm unit. A total of 2 million shares will be distributed to shareholders of record as of October 15th. Each unit will consist of one class A subordinate voting share of NeuroBio along with two warrants.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.